| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000033806 |
| Receipt No. | R000038563 |
| Official scientific title of the study | Blood biomarker of colorectal adenoma and early-stage adenocarcinoma |
| Date of disclosure of the study information | 2018/08/19 |
| Last modified on | 2018/08/19 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Blood biomarker of colorectal adenoma and early-stage adenocarcinoma | |
| Title of the study (Brief title) | Blood biomarker of colorectal tumor | |
| Region |
|
|
| Condition | ||
| Condition | Colorectal adenoma and early-stage carcinoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | In japan, colorectal cancer ranks 1st in all cancer, but prevalence of fecal immnological test(FIT) is still around 30%, and even in examinees with positve FIT, only 50-60% of examinees undergo colonoscopy. In US, cologuard and sept9 have been approved by FDA, but they are not so sensitive in advanced adenoma and early-stage adenocarcinoma. In this study, we determine to identify the blood biomarker which detect advanced adenoma and early stage adenocarcinoma. |
| Basic objectives2 | Others |
| Basic objectives -Others | Identification of blood biomarker of colorectal adenoma and early-stage adenocariconma |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase I |
| Assessment | |
| Primary outcomes | Sensitivity, specifity, and accuracy of the identified blood biomarker |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | NO |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Endoscopic resection | |
| Interventions/Control_2 | Healthy participants | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with high-grade adenoma and early-stage adenocaricnoma with >9mm in size who will undergo endoscopic resection. | |||
| Key exclusion criteria | 1. Pregnant women
2. Patients with small and large bowel stricture 3. inappropriate patients to enroll judged by doctors |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Naoki Ohmiya |
| Organization | Fujita Health University School of Medicine |
| Division name | Department of Gastroenterology |
| Address | 1-98 Dengakugakubo Kutsukake-cho, Toyoake, Aichi |
| TEL | 0562-93-9240 |
| nohmiya@fujita-hu.ac.jp | |
| Public contact | |
| Name of contact person | Naoki Ohmiya |
| Organization | Fujita Health University |
| Division name | Department of Gastroenterology |
| Address | 1-98 Dengakugakubo Kutsukake-cho, Toyoake, Aichi |
| TEL | 0562-93-9240 |
| Homepage URL | |
| nohmiya@fujita-hu.ac.jp | |
| Sponsor | |
| Institute | Fujita Health University School of Medicine, Department of Gastroenterology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Aichi Cancer Research Foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Aichi Cancer Center Hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 藤田保健衛生大学消化管内科(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | Enrollent is ongoing. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038563 |